Investors Flock to Hong Kong's Biotech IPOs Amid Market Thaw
As the biotech sector in Hong Kong begins to recover, investors are increasingly turning their attention to initial public offerings (IPOs) in the industry. This trend signals renewed confidence in the market, highlighting the potential for growth in the region's biotech landscape.